Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6251–6300 of 18417
On February 19, 2024, the Company’s board of directors appointed Steven S. Williamson as the Company’s President and Chief Executive Officer and a Class II member of the board of directors, each as of the Effective Date.
On February 21, 2024, Jazz Pharmaceuticals plc (the “Company”) announced the appointment of Philip Johnson as the Company’s Executive Vice President and Chief Financial Officer, effective as of March 1, 2024.
appointed Benjamin L. Schmitt to serve as the Bancorp’s and Bank’s permanent Senior Vice President, Chief Financial Officer and Treasurer, effective February 20, 2024.
appointed Joseph C. Papa as President and CEO of the Company, effective February 21, 2024.
Haywood Miller, who will step down from his role as interim CEO of the Company, effective February 21, 2024.
On February 21, 2024, Joshua Ballard, Chief Financial Officer of Energy Recovery, Inc., (the “Company”) announced that he intended to resign as Chief Financial Officer effective on June 30, 2024.
On February 15, 2024, Steve Buhaly resigned from his position as the Chief Financial Officer of BioSig Technologies, Inc. (the “ Company ”), effective as of the same date.
On February 21, 2024, The RealReal, Inc. (the “Company”) announced that Ajay Gopal has been appointed by the Board of Directors (the “Board”) of the Company to serve as the Company’s Chief Financial Officer, effective March 18, 2024
Joining the Company effective March 1, 2024, in the role of Executive Vice President and Chief Financial Officer is Mr. Galagher Jeff,
Ashish Sharma resigned as Chief Executive Officer and President of the Company, to be effective as of February 23, 2024.
Mr. Jones will be succeeded as CEO by Mark Miller (such succession, the “CEO Succession”).
On February 14, 2024, the board of directors (the “Board”) of Nikola Corporation (the “Company”) appointed Stephen J. Girsky, the Company’s President and Chief Executive Officer, as the Company’s Acting Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer.
It is expected that Don Cummings, the Company’s current Senior Vice President, Chief Accounting Officer and Controller will be appointed Chief Financial Officer as of June 3, 2024.
Marcia Wadsten notified the Company of her intention to retire as Executive Vice President and Chief Financial Officer as of June 3, 2024.
the Board also appointed Michael S. Iskra to serve as the Company’s Interim Chief Executive Officer and Robert J. Bujarski to serve as the Company’s Interim President, each effective February 21, 2024.
On February 14, 2024, the Board of Directors (the “Board”) of QuidelOrtho Corporation (the “Company”) determined to terminate Douglas C. Bryant, the Company’s President and Chief Executive Officer, effective February 21, 2024.
that the Board of Directors of Olin (the “Board”) has appointed Kenneth Lane, 55, as President and Chief Executive Officer of Olin, effective as of March 18, 2024
Scott M. Sutton, who will be stepping down as President and Chief Executive Officer and Director of Olin on the Effective Date.
Bruce K. Lee, the Company’s President and Chief Executive Officer (“CEO”), and a member of the Board of Directors (the “Board”), informed the Board that he intends to retire by the end of 2024.
On the Effective Date, Florence Neubauer will no longer serve as Interim Chief Financial Officer of the Company.
it had appointed Girish Satya, to serve as the Company’s Chief Financial Officer with an effective date of February 21, 2024
On February 20, 2024, the Board announced that Mr. Robert W. Sharps will become the Chair of the Board following Mr. Stromberg’s retirement, in addition to continuing on as the Chief Executive Officer and President of the Company.
Adrianne Lee, Beyond’s Chief Financial Officer, has been appointed as Beyond’s Chief Financial & Administrative Officer and continues to serve as its principal financial officer and principal accounting officer.
Chandra Holt, age 43, has been appointed as Beyond’s Division Chief Executive Officer, Bed Bath & Beyond, and has been designated as Beyond’s co-principal executive officer.
David Nielsen, Beyond’s Interim Chief Executive Officer and President, has been appointed as Beyond’s Division Chief Executive Officer, Overstock and designated as Beyond’s co-principal executive officer.
On February 17, 2024, Dr. Vincent D. Mattera, Jr., the Chief Executive Officer (“CEO”) of Coherent Corp. (the “Company”), informed the Company’s Board of Directors (the “Board”) of his intent to retire as CEO following the appointment of his successor or otherwise at the end of calendar 2024.
Pursuant to the Transition Agreement, Ms. Anasenes will resign as Chief Financial Officer and Senior Vice President of Finance effective as of the Transition Date
On February 15, 2024, ANSYS, Inc.’s (the “Company”) Board of Directors (the “Board”) appointed Rachel Pyles as Chief Financial Officer and Senior Vice President of Finance of the Company, effective as of February 22, 2024
promoted Justin Lagasse to the position of Senior Vice President – Chief Financial Officer and Controller of the Corporation.
On February 20, 2024, Scott Wheeler notified the Company of his intention to retire from his position as Chief Financial Officer.
Mr. Gignac will join the Company, initially as Executive Vice President, Finance, on April 1, 2024, and will succeed Mr. Ryan as Executive Vice President and Chief Financial Officer on July 1, 2024.
Mr. Ryan will continue to serve as Executive Vice President and Chief Financial Officer of the Company through June 30, 2024, at which time he will retire from that executive officer position.
On February 16, 2024, John Sullivan informed iSun, Inc. (the “Company”) of his decision to resign as Chief Financial Officer of the Company to pursue other opportunities.
On February 20, 2024, Stephen V. Horn, age 38, formerly Senior Vice President, Chief Accounting Officer of the Company, was promoted to Executive Vice President, Chief Financial Officer & Chief Accounting Officer of the Company, effective as of such date.
On February 15, 2024, Malibu Boats, Inc. (the “ Company ”) and Mr. Jack Springer mutually agreed that Mr. Springer will cease to serve as Chief Executive Officer, effective May 17, 2024
On February 15, 2024, Sean Cassidy indicated that he would step down as Chief Financial Officer, Treasurer and principal financial officer of Arvinas, Inc., a Delaware corporation (the “Company”), effective February 29, 2024, to pursue another professional opportunity.
On February 19, 2024, the Board of Directors of the Company appointed Randy Teel, Ph.D., the Company’s current Senior Vice President, Corporate and Business Development, to serve as the Company’s interim Chief Financial Officer, Treasurer and principal financial officer, effective February 29, 2024, while the Company undertakes a search to identify the Company’s next permanent Chief Financial Officer, Treasurer and principal financial officer.
Mr. Vasquez will replace Jeff Fieler, who has been serving as interim Chief Financial Officer since December 1, 2023. Mr. Fieler will continue to serve as a non-independent member of the Board of Directors.
On February 19, 2024, PureCycle Technologies, Inc. (“Company”) appointed Jaime Vasquez, 61, as the Company’s Chief Financial Officer (“CFO”), effective immediately.
On February 14, 2024, Home Federal Bancorp, Inc. of Louisiana (the “Company”) and its wholly owned subsidiary Home Federal Bank (the “Bank”) (collectively, the “Employers”) entered into a Transition Agreement with Glen W. Brown, the Senior Vice President and Chief Financial Officer of each of the Employers.
and Matthew Malriat as Chief Financial Officer
designated Suren Ajjarapu as Chief Executive Officer
On February 14, 2024, Ocuphire Pharma, Inc., (the “Company”) announced the appointment of Nirav Jhaveri as the Company’s Chief Financial Officer (“CFO”), effective February 12, 2024
On February 14, 2024, the Board of Directors (the “Board”) of Janel Corporation (the “Company”) appointed Joseph R. Ferrara, age 59, as Chief Financial Officer, Treasurer and Secretary of the Company, effective as of February 15, 2024 (the “Effective Date”).
Michael Minnick, 57, the Company’s Chief Executive Officer, will assume the role of principal financial and accounting officer of the Company effective upon Mr. Cuneo’s resignation.
On February 15, 2024, Gavin Cuneo notified Crown PropTech Acquisitions (the “ Company ”) of his decision to resign as the co-chief executive officer of the Company, effective immediately.
Effective February 15, 2024, the Company promoted Mr. Timothy Santo, age 47, to Chief Financial Officer.
Craig E. Fraser, who currently serves as the Company’s President, Chief Executive Officer and Chairman of the Board of Directors, will assume the responsibilities of principal financial officer for purposes of the Securities Exchange Act of 1934, as amended, on an interim basis.
On February 15, 2024, Windtree Therapeutics, Inc. (the “Company”) and John A. Tattory mutually agreed to Mr. Tattory’s resignation from his positions as the Interim Chief Financial Officer and principal financial officer of the Company, effective February 15, 2024.
On February 14, 2024, the Company appointed Gayle Jardine to be the Company’s interim Chief Financial Officer, effective immediately, until a permanent replacement is found.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.